Amgen Inc.
AMGN
$269.38
-$3.63-1.33%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 7.83B | 6.55B | 6.68B | 5.85B | 6.55B |
| Total Other Revenue | 363.00M | 355.00M | 303.00M | 259.00M | 287.00M |
| Total Revenue | 8.20B | 6.90B | 6.99B | 6.11B | 6.84B |
| Cost of Revenue | 3.11B | 1.81B | 1.81B | 1.72B | 1.75B |
| Gross Profit | 5.08B | 5.10B | 5.17B | 4.39B | 5.09B |
| SG&A Expenses | 2.27B | 1.34B | 1.29B | 1.26B | 1.57B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 620.00M | -9.00M | 57.00M | 2.00M | -7.00M |
| Total Operating Expenses | 7.53B | 4.22B | 4.26B | 4.04B | 4.64B |
| Operating Income | 668.00M | 2.69B | 2.73B | 2.07B | 2.20B |
| Income Before Tax | 852.00M | 1.95B | 1.61B | 3.44B | 1.75B |
| Income Tax Expenses | 85.00M | 217.00M | 235.00M | 601.00M | 132.00M |
| Earnings from Continuing Operations | 767.00M | 1.73B | 1.38B | 2.84B | 1.62B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 767.00M | 1.73B | 1.38B | 2.84B | 1.62B |
| EBIT | 668.00M | 2.69B | 2.73B | 2.07B | 2.20B |
| EBITDA | 2.05B | 3.58B | 3.62B | 2.97B | 3.11B |
| EPS Basic | 1.43 | 3.23 | 2.58 | 5.32 | 3.02 |
| Normalized Basic EPS | 0.12 | 2.84 | 1.11 | 4.12 | 2.49 |
| EPS Diluted | 1.42 | 3.22 | 2.57 | 5.28 | 2.99 |
| Normalized Diluted EPS | 0.12 | 2.82 | 1.11 | 4.09 | 2.47 |
| Average Basic Shares Outstanding | 535.00M | 535.00M | 535.00M | 534.00M | 535.00M |
| Average Diluted Shares Outstanding | 540.00M | 538.00M | 537.00M | 538.00M | 539.00M |
| Dividend Per Share | 2.13 | 2.13 | 2.13 | 2.13 | 1.94 |
| Payout Ratio | 148.63% | 65.90% | 82.60% | 40.02% | 64.36% |
